Latest stories on VXRT
Vaxart Adds Admiral Bono to Board, Boosting Governance
TipRanks58 · neutralgeneral
Vaxart, Inc. (VXRT) files 8-K
SEC 8-K50 · neutralgeneral
Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors
GlobeNewswire56 · neutralgeneral
Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors
StockTitan56 · neutralgeneral
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
Business Insider74 · bullishproduct/pr
V2X awarded $231.8M U.S. Air Force contract modification
The Fly71 · bullishgeneral
Vaxart, Inc. (VXRT) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow
Seeking Alpha50 · neutralgeneral
Vaxart, Inc. (VXRT) files 8-K
SEC 8-K50 · neutralgeneral
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
V2X General Counsel Sells 3,500 Shares
Yahoo Top48 · neutralgeneral
V2X General Counsel Sells 3,500 Shares
The Motley Fool48 · neutralgeneral
Vaxart, Inc. (VXRT) Q2 2026 Stockholder Fireside Chat Call Transcript
Seeking Alpha63 · neutralproduct/pr
Vaxart granted European patent covering oral norovirus vaccine through 2036
The Fly63 · neutralproduct/pr
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
GlobeNewswire63 · neutralproduct/pr
Vaxart, Inc. (VXRT) files 8-K
SEC 8-K50 · neutralgeneral
Vaxart Earnings Call Balances Safety Wins and Cash Risk
TipRanks56 · neutralearnings
V2X shares gain after securing Marine Corps contract worth up to $500 million
InvestorsHub67 · bullishproduct/pr
Vaxart Q2 Earnings Call Highlights
Yahoo Finance63 · neutralearnings
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding
Seeking Alpha63 · neutralproduct/pr
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Vaxart GAAP EPS of -$0.06 beats by $0.06, revenue of $27.19M beats by $0.98M
Seeking Alpha63 · neutralearnings
Vaxart, Inc. (VXRT) files 8-K
SEC 8-K50 · neutralgeneral
Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
StockTitan55 · neutralearnings